Baylor researchers find tubulin redirects Tau and alpha-synuclein away from toxic aggregation
Scientists at Baylor College of Medicine report that tubulin—the structural protein of cellular transport networks—can divert Tau and alpha-synuclein from forming the toxic clumps associated with Alzheimer's and Parkinson's disease.
Researchers at Baylor College of Medicine have published findings suggesting that tubulin, the protein subunit that assembles into microtubules forming the cell's internal transport network, can interact with Tau and alpha-synuclein in ways that prevent those proteins from condensing into toxic aggregates inside neurones.
Both Tau and alpha-synuclein are well-established players in neurodegenerative disease: hyperphosphorylated Tau tangles are a hallmark of Alzheimer's disease, while alpha-synuclein aggregates—Lewy bodies—are central to the pathology of Parkinson's disease. A dominant research strategy has been to prevent the initial liquid–liquid phase separation of these proteins into droplets. The Baylor team report a different mechanism: rather than blocking condensation outright, tubulin appears to recruit Tau and alpha-synuclein into functional microtubule-associated roles, away from the aggregation pathway.
The specific journal, lead authors, and experimental model system were not detailed in the feed lede available to Genetic Current; readers are directed to the primary publication for mechanistic detail, methodology, and caveats. The findings are at a preclinical research stage.
The work is relevant to researchers in neurodegeneration and cell biology, and to educators and students covering protein quality-control mechanisms, phase separation biology, and the cytoskeleton's role in neuronal homeostasis. It does not constitute clinical guidance.
Plain-language version
For patients, families, and general readers. Educational only — not medical advice.
Scientists at Baylor College of Medicine in the United States have discovered that a protein called tubulin — which helps build the tiny transport tubes inside cells — may play a role in preventing the harmful protein clumps that are seen in Alzheimer's and Parkinson's diseases.
In Alzheimer's disease, a protein called Tau forms tangled clumps inside brain cells. In Parkinson's disease, a different protein called alpha-synuclein forms similar clumps called Lewy bodies. The new research suggests that tubulin can pull these proteins away from clumping and instead put them to useful work inside the cell.
This research was carried out in a laboratory setting and is at an early stage. It does not yet change how either disease is diagnosed or treated. This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary source ScienceDaily · 2026-06-21Tubulin prevents toxic brain protein clumps linked to Alzheimer's and Parkinson's